mortality/aging
• after administration with DSS
|
digestive/alimentary system
• reduced in number, contain less stainable material and oddly shaped
|
• acinar cells have swollen ER
|
• decreased colon length in 16 month old mice with numerous cellular defects of the lamina propria and epithelium in the small intestine and colon
• reduced mucin content
|
• numerous cellular defects of the lamina propria and epithelium in the small intestine and colon in 16 month old mice
|
• reduced in number, contain less stainable material and oddly shaped
|
• 16 month old mice exhibit shortening of the colon, cellular defects of the lamina propria and epithelium in the small intestine and colon, neutrophilic and lymphocytic infiltrates in the lamina propria of the small intestine, villus fusion, thickening submucosa and crypt abcesses unlike wild-type mice
|
• mice treated with DDS exhibit increased weight loss, dramatic leukocyte recruitment in the colon, crypt loss in the colon and mortality compared with wild-type mice
• hypersensitivity to DSS is not dependent on hematopoietic cells
|
growth/size/body
• after administration with DSS
|
homeostasis/metabolism
• after administration with DSS
|
immune system
• 16 month old mice exhibit shortening of the colon, cellular defects of the lamina propria and epithelium in the small intestine and colon, neutrophilic and lymphocytic infiltrates in the lamina propria of the small intestine, villus fusion, thickening submucosa and crypt abcesses unlike wild-type mice
|
• mice treated with DDS exhibit increased weight loss, dramatic leukocyte recruitment in the colon, crypt loss in the colon and mortality compared with wild-type mice
• hypersensitivity to DSS is not dependent on hematopoietic cells
|
endocrine/exocrine glands
• acinar cells have swollen ER
|
• reduced in number, contain less stainable material and oddly shaped
|
cellular
• reduced in number, contain less stainable material and oddly shaped
|